Nickel-titanium stent in the treatment of benign prostatic hyperplasia analysis of 75 cases of acute urinary retention in.docVIP

 PAGE \* MERGEFORMAT 12 Nickel-titanium stent in the treatment of benign prostatic hyperplasia analysis of 75 cases of acute urinary retention in Keywords:: benign prostatic hyperplasia; interventional stent [Abstract] Objective To summarize the nickel-titanium shape memory alloy mesh stent treatment of senile prostatic hyperplasia. Methods 75 cases of elderly patients with pre-owned aircraft measured IPSS28.5 ± 3.6, QOLamp;gt; 4. Interventional into nickel-titanium shape-memory alloy mesh stent, was after a year, 2 years, 3 years, 4 years follow-up. Results after a good year rate of 87.3%, 86.0% excellent and good rate for 2 years, 3 years of excellent and good rate was 77.8%, 4 years of excellent and good rate 73.5%. Conclusion Interventional transurethral stent placement can be used as elderly patients with benign prostatic hyperplasia methods. [Keywords:] prostatic hyperplasia; interventional stent Nickel-titanium shape-memory alloy stent for the BPH patients with acute urinary retention. (Analysis of 75 cases) [Abstract] Objective To summarize the clinical effect in using nickel-titanium shape-memory alloy stent to cure prostate hyperplasia. Methods Seventy-five old patients were IPSS 28.5 ± 3.6, QOLamp;gt; 4 before operation. The patients using nickel-titanium shape - memory alloy stent were followed up for 1 to 4 years after operation.Results The successful rates of 1 year, 2 years, 3 years and 4 years are 87.3%, 86.0%, 77.8% and 73.5%. Conclusion The results indicated that nickel - titanium shape-memory alloy stent was technique in the treatment of benign prostatic heperplasia. [Keywords:] prostatic hyperplasia; interventional method of urethreal stent placing. Anterior urethral obstruction is caused by a common cause of acute urinary retention, and benign prostatic hyperplasia, urethral injury is anterior urethral obstruction caused by common diseases, of which the most common benign prostatic hyperplasia. Over the past 10 years, as re